18 results
Eichhoff's Test in de Quervain's Tenosynovitis

The Eichhoff test is used to assess for de Quervain's tenosynovitis,
condition that causes ... ulnar deviation ... Tenosynovitis #clinical ... physicalexam #sports #msk ... #orthopedics #rheumatology
Eichhoff's Test in de Quervain's Tenosynovitis

The Eichhoff test is used to assess for de Quervain's tenosynovitis,
condition that causes ... ulnar deviation ... Tenosynovitis #clinical ... physicalexam #sports #msk ... #orthopedics #rheumatology
Eichhoff's Test in de Quervain's Tenosynovitis

The Eichhoff test is used to assess for de Quervain's tenosynovitis,
condition that causes ... ulnar deviation ... Tenosynovitis #clinical ... physicalexam #sports #msk ... #orthopedics #rheumatology
Eichhoff's Test in de Quervain's Tenosynovitis

1) Patient makes a fist with fingers wrapped around the thumb
2)
Eichhoff's Test ... ulnar deviates ... Tenosynovitis #clinical ... physicalexam #sports #msk ... #orthopedics #rheumatology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE) Clinical ... Disease, PRES Pathophysiology ... autoantibodies that will cause ... Puncture, EEG Treatment ... CNS #neurology #rheumatology
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
SLE) - Diagnosis and ... 40, F:M 9:1 • Clinical ... Positive in 60-80% of cases ... life-threatening • Treatment ... Management #Summary #rheumatology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... constitutional symptoms • Treatment ... 40, F:M 9:1 • Clinical ... life-threatening • Treatment ... comparison #table #rheumatology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... blood donor • Pathophysiology ... without other cause ... : 33% • Treatment ... : No • Treatment
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... accumulation of clinical ... Drugs, Unknown cause ... Treatment: • ... #summary #rheumatology
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
survival is 93-95% Pathophysiology ... renal failure Clinical ... symptoms are not caused ... skin (16-32%): lupus ... anterior/posterior MSK